The Predictive Value of 18f-FDG-Pet Early Evaluation in Patients With Metastatic Gastric Adenocarcinoma Treated With Chemotherapy Plus Cetuximab

Gastric Cancer - Germany
doi 10.1007/s10120-007-0438-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Predictive Value of FDG-PET in Patients With Advanced Medullary Thyroid Carcinoma Treated With Vandetanib

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2017English

Predictive Value of TLR7 Polymorphism for Cetuximab-Based Chemotherapy in Patients With Metastatic Colorectal Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Prognostic and Predictive Values of Metabolic Parameters of 18f-FDG PET/CT in Patients With Non-Small Cell Lung Cancer Treated With Chemotherapy

Molecular Imaging
Nuclear MedicineRadiologyMolecular MedicineCondensed Matter PhysicsImagingBiotechnologyBiomedical Engineering
2019English

Prognostic Value of 18f-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated With Docetaxel

Contrast Media and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2019English

Dual-Time-Point 18f-FDG PET/CT in Patients With Colorectal Cancer: Clinical Value of Early Delayed Scanning

Annals of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2012English

[18F]FDG PET/MRI of Patients With Chronic Pain Alters Management: Early Experience

EJNMMI Physics
InstrumentationNuclear MedicineRadiologyRadiationImagingBiomedical Engineering
2015English

Efficacy of 18f-FDG PET/CT in the Evaluation of Patients With Recurrent Cervical Carcinoma

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2009English

Gastric Adenocarcinoma Is Concurrent With Metastatic Neuroendocrine Cancer Treated With Nivolumab and Chemotherapy: A Case Report

Molecular and Clinical Oncology
Cancer ResearchOncology
2018English

Erratum To: 18f-Fluorocholine PET/CT for Early Response Assessment in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy